Background/Aims: Cardiovascular complications are responsible for increased mortality and morbidity in chronic kidney disease (CKD) patients. Functional and structural changes of peritoneal membrane are reported in CKD patients both on conservative treatment and on renal replacement therapy (RRT). The aim of the study was to assess the structure of peritoneal membrane small arteries (precapillary arterioles) in diabetic and non-diabetic CKD stage 5 patients before initiation of peritoneal dialysis (PD) and evaluate its relationship with heart and large arteries abnormalities and with selected biochemical parameters. Methods: Evaluation of 42 CKD stage 5 patients before starting PD. Diabetic (n=26) and non-diabetic (n=16) patients were compared. Peritoneal membrane samples were taken during Tenckhoff catheter insertion. Histopathological evaluation of peritoneal precapillary arterioles (arteriolar evaluation) with measurement of wall thickness (WT) and calculation of lumen/vessel (L/V) ratio was performed in each patients. Echocardiography, intima media thickness (IMT), pulse wave velocity (PWV), ambulatory blood pressure monitoring (ABPM) and biochemical parameters
Introduction
Cardiovascular disease (CVD) is overexpressed in chronic kidney disease (CKD) patients. The risk of CVD increases with kidney function decline. Atherosclerotic CVD accounts for more than half of death in CKD patients and cardiovascular mortality is 10 to 30 fold higher than that seen in general population. Cardiovascular complications related with accelerated atherosclerosis are observed even in young patients [1] [2] [3] . The high CVD risk in CKD is associated with well -known traditional and non-traditional risk factors [4, 5] . The peritoneal microcirculation is an intricate network which connect systemic vasculature and the peritoneal cavity. Many former studies were focused on heart and large arteries assessment but the data concerning peritoneal small vessels disease in CKD are sparse. Metabolic disturbances related to CKD, long lasting hypertension and diabetes mellitus are responsible for functional and structural damage of this microcirculation. The consequences of these processes is premature and aggressive atherosclerosis and reduced capillary density which also affects peritoneal microcirculation [6, 7] . Moreover, it is well documented that bioincompatible fluids used in long-term peritoneal dialysis (PD) treatment, peritonitis episodes, may also impact on peritoneal membrane (PM) function and structure. PM changes such as: interstitial fibrosis (thickening of submesothelial interstitial layer) and hyalinizing vasculopathy may be initiated in predialysis pts and may aggravate during PD treatment [8] [9] [10] [11] . There are few methods of assessment of PM microcirculation such as: microvascular density evaluation, analysis of angiogenesis-regulating proteins expression -vascular endothelial growth factor (VEGF), vascular endothelial growth factor receptor (VEGFR), angiopoietin 1 (Angpt1), angiopoietin2 (Angpt2). Histologic evaluation of PM morphology with average peritoneal thickness and peritoneal arteriolar structure assessment is another precious method. We hypothesize that functional and structural changes of peritoneal membrane arteriolar structure in CKD patients are initiated at early stages of disease and progress with renal function decline. Moreover, we assume that changes in peritoneal arteriolar proceed or are parallel to large vessels changes. The aim of the study was to evaluate peritoneal membrane arteriolar structure and to establish any relationships between arteriolar parameters, heart structure, large arteries parameters (evaluated using non-invasive methods) and laboratory parameters in CKD stage 5 patients.
Materials and Methods
42 Caucasian patients (pts) entered the study. There were: 19F and 23M (mean age 51.3±17.1). All pts were at stage 5 of CKD before initiating peritoneal dialysis as a first option of RRT. There was no need to start urgent hemodialysis. The pts were recruited from Outpatient Clinic of Department of Nephrology, Hypertension and Internal Medicine at Ludwik Rydygier University Hospital in Bydgoszcz and one local Nephrology Outpatient Clinic located in our region. The causes of CKD were: diabetic kidney disease - 26pts (typ 1-9pts /typ2 -17pts), chronic glomerulonephritis (CGN) confirmed by renal biopsy -7pts; tubulointerstitial nephropathy-4pts, obstructive nephropathy -3pts; hypertensive nephropathy2pt; In further analysis patients were divided into 2 groups: diabetic (26pts) and non-diabetic (16 pts). Inclusion criteria were: age >18years old; stable clinical condition 4 weeks prior to enrolment, no signs of inflammation (CRP<5, 0mg/L), written informed consent, PD as a first option of RRT. Exclusion criteria were: active immunosuppressive therapy. Comorbid conditions at the onset of the study were: coronary artery disease (CAD) diagnosed in 15 pts, hypertension-28pts, symptoms of congestive heart failure (CHF) were present in 9pts; 1 patients was after transient ischemic attack (TIA) incident. The patients who suffered from hypertension, required 2 or more antihypertensive agents. Treatment of hypertension was in accordance with current guidelines of ESH/ESC. The goal of treatment was to reach blood pressure below<140/90mmHg. The following medications were prescribed: angiotensin converting enzyme inhibitors (ACE-Is) -35 pts, angiotensin receptor blockers (ARBs) -7pts, calcium channel blockers -27; β-blockers -15pts, loop diuretics -42 pts. Patients who reached end-stage kidney disease and there was eGFR<20ml/min according to CKD-EPI formula in diabetic kidney disease and eGFR<15ml/min in nondiabetic cases were offered PD as a first renal replacement therapy option. 3-4 weeks after Tenckhoff catheter insertion, patients started continuous ambulatory peritoneal dialysis (CAPD) than, 2 months later they were transferred to conventional automated peritoneal dialysis (APD) delivered by Baxter (USA). Renal anemia was treated using darbepoetin-alfa subcutaneously according to KDIGO Clinical Practice Guidelines to reach hemoglobin level between 10, 0g/dl to 11, 5g/dl. Chronic kidney disease -mineral and bone disorder (CKD-MBD) were treated according to KDIGO guidelines 2016 (Uptade on the management of CKD-MBD) using conventional therapy: vitamin D (alfacalcidol daily in a dose from 0, 25µg to 0, 5µg daily) and calcium-phosphorus binders (calcium carbonate in a dose from 3, 0g daily to 6, 0g daily) and noncalcium phosphorus binder (sevelamer hydrochloride in a dose: 3 x 0, 8g daily).
Evaluation of small arteries of peritoneal membrane
To assess structure of peritoneal small arteries (peritoneal arterioles) peritoneal membrane specimens (from parietal peritoneum) at least 3cm width, were taken during Tenckhoff catheter insertion. They were immediately fixed in 10% buffered formalin solution. Following the standard procedure, tissue samples were processed and embedded in paraffin blocks, and then cut into 3-4µm slides and stained with hematoxylin and eosin. Peritoneal arterioles were analyzed after the standardized immunohistochemical procedure using anti-CD31 antibodies. The visual analysis of the peritoneal arteries was performed using the Imaging System NIS ELEMENTS AR. Part of that system was light microscopy connected with computer. Each histologic sample were evaluated with magnification 40x. 5 arteries obtained from each patient were evaluated. Thickness of vascular wall (assessed in 5 separate points), luminal diameter and external arteriolar diameter were measured in each patient. Results were expressed in micrometers (µm). Thanks to luminal diameter and external arteriolar diameter measurements, ratio of luminal diameter to whole arteriolar diameter (L/V) were calculated in each individual. These values reflected the patency of vessels. Lowering of L/V ratio is an indicator of arteriolar narrowing. All histopathological images were evaluated by 2 investigators i.e. nephrologist and experienced pathologist. Precapillary arterioles with external diameter range 25-75µm selected by experienced pathologist were chosen for detailed measurements. The distance was measured in one short axis of the vessel. The concept of these measurements is presented in Fig.1 . Evaluation of heart structure and large arteries Pulse wave velocity measurements. Carotid-femoral PWV was measured using the Complior® device (Artech Medical, Pantin, France). Two transducers -one positioned over the carotid artery and second over the femoral artery -were used to measure the time delay between pulse waves. Time delay was measured on 10 successive beats, and then averaged. The distance between the carotid artery (suprasternal notch) and the femoral artery was measured externally. PWV was calculated according to the formula: PWV = distance (m)/ time delay (s). PWV measurements were taken in duplicate and averaged.
Intima-media thickness measurements
Common carotid arteries were examined in all patients, in the supine position after a 5-minute rest, with high resolution real-time ultrasonography using an 11 MHz linear probe. Measurements were performed on frozen mode images. Intima-media thickness (IMT) was measured 10-30 mm proximally to the carotid bifurcation, on the carotid far wall, in three points, free of atherosclerotic plaques. Measurements were done on both common carotid arteries and the results were averaged.
Echocardiography. Echocardiographic examination was performed in each patients at the beginning of the study. The measurements of intraventricular septum thickness in end-diastole (IVSd), left ventricular internal dimension in end-diastole (LVIDd), posterior wall in end-diastole (PWd) were performed. Left ventricular mass (LVM), left ventricular mass index, ejection fraction (EF) and left ventricle relative wall thickness (RWT) were calculated. The measurements were performed in accordance with latest guidelines given by the American Society of Echocardiography. Left ventricular systolic function impairment was defined as EF <55%. Left ventricular hypertrophy (LVH) was defined as LVMI>95g/m² for women and LVMI>115g/m² for men.
Ambulatory blood pressure monitoring (ABPM). 24 hours ambulatory blood pressure monitoring (ABPM) using A&D TM 2430 device (Japan), was performed in each patient at the onset of the study. Mean values of systolic blood pressure (SBP), diastolic blood pressure (DBP), mean arterial pressure (MAP), and pulse pressure (PP) were analyzed.
Biochemical evaluation. Assessment of serum albumin (SA), C-reactive protein (CRP), hemoglobin (Hgb), total cholesterol (TCH), serum calcium (Ca), serum phosphorus (P), PTH, transferrin saturation (TSAT%) were performed at the beginning of the study.
Statistical analysis
Statistical analysis was performed using the Statistica 7.0 PL software (StatSoft Inc., Tulsa, OK, USA). The obtained data are presented as mean ± standard deviation (SD) and the median and top and bottom quartiles are given for variables that were not normally distributed. Distribution of variables was analyzed using the Shapiro-Wilk test. Statistical analysis was performed using the Student's t-test. If any variable was not normally distributed, the U Mann-Whitney test was used. Qualitative data were compared by means of the c 2 -test. Linear correlation between variables was analyzed using: Spearman rank correlation coefficient (for samples with non-normal distribution) and Pearson's correlation coefficient ( for samples with normal distribution) also. P value < 0, 05 was considered as statistically significant.
Ethical approval
The study protocol was approved by the local Bioethics Committee of Nicolaus Copernicus University in Toruń. Informed consent was obtained from all patients included in the study.
Results
Clinical characteristics of the patients is given in Table 1 .
Comparison of cardiovascular system indices and morphometric analysis of peritoneal membrane arteriolar structure in diabetic and non-diabetic CKD group are presented in Table 2 .
There were not any statistically significant differences in the most investigated parameters except PWV.
PWV value was statistically significantly higher in diabetic kidney disease pts in compare to non-diabetic pts.
In non-diabetic CKD pts some statistically significant linear correlation were found (Table 3 ). There were linear correlation between PWV vs PP (R=0, 58; p=0, 03); PWV vs BSA (R=0, 59; p=0, 03); PWV vs DHgb (R=0, 63;p=0, 02); IMT vs age (R=0, 79; p=0, 002); IMT vs BSA (R=0, 86; p=0, 003); IMT vs BMI (R=0, 70;p=0, 01); WT vs DP (R=-0, 62; p=0, 02); WT vs DHb (R=-0, 54; p=0, 05). Moreover, in diabetic CKD pts there were statistically significant correlation between: PWV vs age (R=0, 75; p=0, 02); IMT vs BSA (R=0, 76; p=0, 01); WT vs DP (R=-0, 93; p=0, 001); WT vs DBP (R=0, 64; p=0, 04); PWV vs IMT (R=0, 80; p=0, 002). We performed analysis of arteriolar indices in subpopulations of patients with and without cardiovascular disease (CVD) (i.e CAD and CHF). Date are presented in Table 4 and  Table 5 .
The linear correlation between arteriolar indices and c-IMT are presented. (Fig. 2 and  Fig. 3) .
We do not have any drop outs during the study because of patient sudden death. There was 1 incident of NSTEMI in diabetic patient. 
Discussion
The peritoneal microcirculation is a network which connect the systemic vasculature and peritoneal cavity. This special network participates in numerous physiological conditions like solute and water transport, regulation of ultrafiltration, delivery of nutrients, hormones, leukocytes to inflammation areas. The peritoneal microcirculation consists of arterioles, capillaries and venules. Arterioles which range in diameter is from 5 to 100µm give rise directly to the metaarterioles (10-20µm in diameter) and to capillaries (5-10µm in diameter). Metaarterioles can bypass capillary circulation and serve as channels to venules [12, 13] .
CKD patients present extremely high CV risk and high CV mortality and morbidity. It was widely shown in many studies that cardiovascular status at the beginning of dialysis greatly affects patients outcomes [5] . The population at extremely high risk are patients with diabetes.
The aim of our study was to assess peritoneal membrane arteriolar structure and perform global CV system status assessment using non-invasive methods in patients with advanced CKD just before initiation of PD with comparison of diabetic and non-diabetic population. The peritoneal microcirculation function and structure may be affected by many physiological and pathological conditions and specific processes related to peritoneal dialysis. The influence of age, hypertension, diabetes mellitus, subclinical inflammation and uremia per se had been reported [14] . Conventional high-glucose based fluids used in long-term PD treatment are responsible for aggravation of PM fibrosis and alterations in peritoneal microcircluation. Enhanced neoangiogenesis and progressive obliterative vasculopathy are common in PD patients [15, 16] . Different degrees of vasculopathy with vessel wall thickening, hyaline material deposits and vessels lumen obliteration may be observed in PD pts but these processes are initiated in predialysis period.
In our study we did not find any statistically significant differences in peritoneal arteriolar indices i.e. peritoneal wall thickness (WT) and L/V ratio between diabetic and nondiabetic patients. There was only tendency to lower values of L/V ratio in diabetic patients. It may indicate higher degree of arteriolar obliteration in this group. Peritoneal arteriolar wall thickness was greater in the analyzed diabetic patients ( Table 2) . Assessment of population with overt CAD or CHF and without ones show no differences in most of arteriolar indices except L/V ratio (statistically significant differences in population with and without CHF) ( Table 4 and Table 5 ). It seems that arteriolar obliteration may be even worse in population without overt CHF. We found linear correlations between WT vs DP (R=-0, 62; p=0, 02); WT vs DHb (R=-0, 54; p=0, 05) in non-diabetic group that may indicate the influence of calciumphosphorus metabolism derangements and renal anemia on arteriolar structure. The positive linear correlation between WT vs DBP (R=0, 64; p=0, 04) in diabetic subpopulation may indicate the influence of systemic hypertension on peritoneal arteriolar structure. We suppose that uremia, hypertension and hyperglycemia affect both PM arteriolar and macrocirculation function and structure.
Ooi et al. analyzed microvasculature in CKD patients by measurements of retinal vessels diameter. They found smaller diameter of vessels of CKD stage 3-5 pts in compare to stage 1-2 pts but individuals with CKD stage 5 and diabetic patients had larger mean vessel diameter than non-diabetics. The authors concluded that the process of narrowing of microvasculature in CKD patients increases progressively with eGFR reduction [17] . Burkhardt et al. in their study wanted to assess the degree of "uremic microangiopathy" by means of measuring microvascular density in biopsies of the peritoneal omentum of 23 CKD stage 5 children. They proved that microvascular density was significantly reduced in omental biopsies and it was associated with diminished of angiopoetin 2 (Angpt2) signaling [18] . They introduced the term "uremic microangiopathy" into the terminology of small vessels disease in CKD patients. Capillary rarefaction was also documented in skeletal muscles and in myocardium of animals with experimental CKD [18] . Honda et al. in their study pointed out that average peritoneal membrane thickness and lumen/vessel diameter ratio were useful morphological parameters which may be adopted to qualify the severity of peritoneal alterations in uremic and PD patients. The lumen/vessel diameter ratio was lower in uremic patients than control and progressively decreased during PD [19] . Savidaki et al. compared alterations in peritoneal membrane in patients who had just started PD with those who completed 4 years period of CAPD. He found that structural changes (loss of mesothelial cells, thickening of submesothelial collagenous zone, vascular hyalinosis) were observed in the peritoneal membrane of uremic patients and those changes became worse after 4 years of CAPD treatment. In his study structural changes were not followed by functional changes (changes in peritoneal equilibration test-PET and dialysis adequacy) during the first 4 years of treatment [20] . Contreras-Velazquez in his study compared peritoneal histology of uremic diabetic and non-diabetic patients starting PD. As a control, he used non-diabetic, nonuremic patients who underwent non-complicated elective abdominal surgery. All peritoneal morphological changes were more emphasized in the diabetic group, and especially in this group, there was a higher proportion of vascular wall thickening/sclerosis than in nondiabetic individuals. The most important predictor of peritoneal vessel changes and clinical outcomes was diabetes (stronger than uremia per se) and hypoalbuminemia [21] .
Besides arteriolar structure we analyzed heart structure and performed non-invasive large arteries assessment. We did not find any statistically significant difference in echocardiographic parameters between analyzed diabetic and non-diabetic population. In our opinion these results are related with good BP control and common use of ACE-I and sartans in treatment of hypertension in analyzed population before RRT initiation.
Another part of our investigation was assessment of c-IMT in all participants. Increased c-IMT complex is a well-known parameter which reflects early atherosclerotic lesions and indicate higher cardiovascular risk in patients with hypertension and also predict incident CKD in the general population [22] . There were not any statistically significant differences in c-IMT measurements in both analyzed groups (Table 2) . We found linear correlation between c-IMT and arteriolar indices in population with overt CVD i.e positive correlation between c-IMT and L/V ratio and negative correlation between c-IMT and WT (Fig. 2 and Fig. 3) . The simple explanation of these associations may be difficult. We have not find any similar association in other authors reports. Honda et al. in his study found positive correlation between WT and peritoneal thickness in uremic patients and PD patients and negative correlation between L/V ratio and PD duration [19] . We assume that there is relationship between arteriolar structural changes and large arteries changes. Previous studies in patients with CKD stage 1-5 found the tendency of c-IMT value to rise in subsequent groups of patients along with eGFR decrease [1, 23] . Other authors did not find any differences between c-IMT values in analyzed groups of CKD predialysis patients, patients treated with hemodialysis and PD and control group [24] . It is worth to emphasize that assessment of c-IMT complex together with eGFR and proteinuria evaluation and presumably with arteriolar indices Moreover, in our study we performed PWV measurements in all analyzed patients. We found statistically significant higher PWV values in diabetic patients than in non-diabetic (p=0, 029) ( Table 2) . PWV which reflects arterial stiffness is willingly assessed by many investigators in different population of CKD patients such as predialysis, hemodialysis, PD and kidney transplant recipients. Stróżecki et al. found increased arterial stiffness in nondialyzed diabetic kidney disease patients. In this group PWV was significantly higher in compared with individuals without diabetes and control group. Moreover, these researchers found increased accumulation of advanced glycation end-products (AGEs) particularly in diabetic patients, but their results are not sufficient to confirm causal role of AGEs in arterial stiffening [25] . We found positive linear correlation between PWV and c-IMT (diabetic group) that may be a sign of global arteries derangements in CKD patients. We also found positive linear correlation between PWV and age which was confirmed by other authors ( Table 3) .
The important limitation of our study was the fact that we were unable to compare specimens of the peritoneal membrane with similar ones obtained from patients with earlier CKD stages (stage 2-4) and from patients on chronic PD treatment. Moreover, we are unable to refer our results to control group because the study design did not consider to make any comparison with normal peritoneal membrane. We were more interested to make a division into groups with and without diabetic kidney disease and perform comparison between them. We are aware that the accurate histopathological peritoneal membrane assessment is based on evaluation of not only peritoneal arteries or veins but depends on assessment of peritoneal thickness (thickness of submesothelial compact collagenous zone) or peritoneal vessels density. In our study we evaluate a small part of peritoneal microcirculationarteriolar morphology but it was our assumption to compare it with macrocirculation.
We suppose that arteriolar damage can be initiated at early stage of CKD, may progress with renal function decline and it may be parallel to macrocirculation damage. We suspect that arteriolar condition of peritoneal membrane seems to be worse in diabetic kidney disease in compare to non-diabetic patients. Further studies are necessary to prove these assumptions.
Conclusion
Peritoneal membrane arteriolar damage seems to be an integrated part of cardiovascular system damage in CKD stage 5 patients. The peritoneal membrane arteriolar structure changes seems to be increased in diabetic kidney disease patients. Further studies are required and non-invasive markers are necessary to evaluate function and structure of peritoneal microcirculation in advanced CKD before starting RRT.
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